Frizzled 4 Antibody
Référence MBS8582061-0,1mL-FITC
Conditionnement : 0.1mL(FITC)
Marque : MyBiosource
Frizzled 4 (FZD4) Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS8582061MBS8582061 is an antibody targeting FZD4. Also known as Frizzled 4 Antibody. Reactive in Human, Mouse, Rat, Pig. Host: Rabbit. Rabbit polyclonal antibody to Frizzled 4 More details
Product Overview
Online Datasheet in PDFProduct Name
Frizzled 4 (FZD4), Polyclonal Antibody
Full Product Name
Frizzled 4 Antibody
Product Gene Name
anti-FZD4 antibody
Product Synonym Names
Frizzled-4; Fz-4; hFz4; FzE4; CD344
Clonality
Polyclonal
Isotype
IgG
Host
Rabbit
Species Reactivity
Human, Mouse, Rat, Pig
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH7.3, 30% glycerol, and 0.01% sodium azide.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Specificity
Recognizes endogenous levels of Frizzled 4 protein.
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C for one year. Avoid freeze/thaw cycles.
Molecular Weight
59,881 Da
Chromosome Location
Chromosome: 11; NC_000011.9 (86656717..86666440, complement). Location: 11q14.2
OMIM
133780
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the center region of human Frizzled 4. The exact sequence is proprietary.
Product Categories/Family for anti-FZD4 antibody
Primary Antibody
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-FZD4 antibody
Western Blot (WB)
Application Notes for anti-FZD4 antibody
WB: 1:500-1:1000
Other Notes
Small volumes of anti-FZD4 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for FZD4. It may not necessarily be applicable to this product.
NCBI Official Full Name
frizzled-4
NCBI Official Synonym Full Names
frizzled family receptor 4
NCBI Official Symbol
FZD4
NCBI Official Synonym Symbols
Fz4; EVR1; FEVR; Fz-4; FzE4; GPCR; hFz4; CD344; FZD4S
UniProt Protein Name
Frizzled-4
UniProt Synonym Protein Names
FzE4
Protein Family
Frizzled
UniProt Gene Name
FZD4
UniProt Synonym Gene Names
Fz-4; hFz4
UniProt Entry Name
FZD4_HUMAN
NCBI Protein Information
frizzled-4; frizzled homolog 4; WNT receptor frizzled-4; frizzled 4, seven transmembrane spanning receptor
NCBI Summary for FZD4
This gene is a member of the frizzled gene family. Members of this family encode seven-transmembrane domain proteins that are receptors for the Wingless type MMTV integration site family of signaling proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. This protein may play a role as a positive regulator of the Wingless type MMTV integration site signaling pathway. A transcript variant retaining intronic sequence and encoding a shorter isoform has been described, however, its expression is not supported by other experimental evidence. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for FZD4
FZD4: Receptor for Wnt proteins. Most of frizzled receptors are coupled to the beta-catenin (CTNNB1) canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin (CTNNB1) and activation of Wnt target genes. Plays a critical role in retinal vascularization by acting as a receptor for Wnt proteins and norrin (NDP). In retina, it can be both activated by Wnt protein-binding, but also by a Wnt-independent signaling via binding of norrin (NDP), promoting in both cases beta-catenin (CTNNB1) accumulation and stimulation of LEF/TCF-mediated transcriptional programs. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. Defects in FZD4 are the cause of vitreoretinopathy exudative type 1 (EVR1); also known as autosomal dominant familial exudative vitreoretinopathy (FEVR) or Criswick- Schepens syndrome. EVR1 is a disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease-related abnormality is an arc of avascular retina in the extreme temporal periphery. Belongs to the G-protein coupled receptor Fz/Smo family.
Protein type: Membrane protein, multi-pass; Receptor, GPCR; Membrane protein, integral; GPCR, Fz/Smo family
Chromosomal Location of Human Ortholog: 11q14.2
Cellular Component: cell surface; integral to plasma membrane; integral to membrane; plasma membrane; intercellular junction
Molecular Function: G-protein coupled receptor activity; Wnt-protein binding; Wnt receptor activity; protein binding; protein homodimerization activity; protein heterodimerization activity; cytokine binding; ubiquitin protein ligase binding; PDZ domain binding
Biological Process: positive regulation of JNK activity; Wnt receptor signaling pathway; positive regulation of transcription, DNA-dependent; Wnt receptor signaling pathway through beta-catenin; progesterone secretion; locomotion during locomotory behavior; neuron differentiation; G-protein coupled receptor protein signaling pathway; Wnt receptor signaling pathway, calcium modulating pathway; sensory perception of sound; regulation of vascular endothelial growth factor receptor signaling pathway; positive regulation of transcription factor activity; vasculogenesis
Disease: Exudative Vitreoretinopathy 1
Show more Protein type: Membrane protein, multi-pass; Receptor, GPCR; Membrane protein, integral; GPCR, Fz/Smo family
Chromosomal Location of Human Ortholog: 11q14.2
Cellular Component: cell surface; integral to plasma membrane; integral to membrane; plasma membrane; intercellular junction
Molecular Function: G-protein coupled receptor activity; Wnt-protein binding; Wnt receptor activity; protein binding; protein homodimerization activity; protein heterodimerization activity; cytokine binding; ubiquitin protein ligase binding; PDZ domain binding
Biological Process: positive regulation of JNK activity; Wnt receptor signaling pathway; positive regulation of transcription, DNA-dependent; Wnt receptor signaling pathway through beta-catenin; progesterone secretion; locomotion during locomotory behavior; neuron differentiation; G-protein coupled receptor protein signaling pathway; Wnt receptor signaling pathway, calcium modulating pathway; sensory perception of sound; regulation of vascular endothelial growth factor receptor signaling pathway; positive regulation of transcription factor activity; vasculogenesis
Disease: Exudative Vitreoretinopathy 1
Research Articles on FZD4
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-FZD4 antibody
| Reference Product | PubMed Publications |
|---|---|
| DVL2 antibody | >3 publications with FZD4 and DVL2 |
Pathways associated with anti-FZD4 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Basal Cell Carcinoma Pathway antibodies | Basal Cell Carcinoma Pathway Diagram |
| Basal Cell Carcinoma Pathway antibodies | Basal Cell Carcinoma Pathway Diagram |
| Class B/2 (Secretin Family Receptors) Pathway antibodies | Class B/2 (Secretin Family Receptors) Pathway Diagram |
| GPCR Ligand Binding Pathway antibodies | GPCR Ligand Binding Pathway Diagram |
| HTLV-I Infection Pathway antibodies | HTLV-I Infection Pathway Diagram |
| HTLV-I Infection Pathway antibodies | HTLV-I Infection Pathway Diagram |
| Hippo Signaling Pathway antibodies | Hippo Signaling Pathway Diagram |
| Hippo Signaling Pathway antibodies | Hippo Signaling Pathway Diagram |
| Melanogenesis Pathway antibodies | Melanogenesis Pathway Diagram |
| Melanogenesis Pathway antibodies | Melanogenesis Pathway Diagram |
Diseases associated with anti-FZD4 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Retinal Diseases Antibodies | >52 publications with FZD4 and Retinal Diseases |
| Congenital Abnormalities Antibodies | >8 publications with FZD4 and Congenital Abnormalities |
| Inflammation Antibodies | >6 publications with FZD4 and Inflammation |
| Abnormalities, Multiple Antibodies | >4 publications with FZD4 and Abnormalities, Multiple |
| Exudative vitreoretinopathy 1 Antibodies | >3 publications with FZD4 and Exudative vitreoretinopathy 1 |
| Carcinoma Antibodies | >3 publications with FZD4 and Carcinoma |
| Lung Neoplasms Antibodies | >2 publications with FZD4 and Lung Neoplasms |
| Urinary Bladder Neoplasms Antibodies | >2 publications with FZD4 and Urinary Bladder Neoplasms |
| Heart Diseases Antibodies | >2 publications with FZD4 and Heart Diseases |
| Breast Neoplasms Antibodies | >2 publications with FZD4 and Breast Neoplasms |
Organs/Tissues associated with anti-FZD4 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Eye Antibodies | >53 publications with FZD4 and Eye |
| Vascular Antibodies | >32 publications with FZD4 and Vascular |
| Embryonic Tissue Antibodies | >13 publications with FZD4 and Embryonic Tissue |
| Lung Antibodies | >11 publications with FZD4 and Lung |
| Brain Antibodies | >11 publications with FZD4 and Brain |
| Muscle Antibodies | >8 publications with FZD4 and Muscle |
| Heart Antibodies | >6 publications with FZD4 and Heart |
| Kidney Antibodies | >6 publications with FZD4 and Kidney |
| Bone Antibodies | >5 publications with FZD4 and Bone |
| Liver Antibodies | >4 publications with FZD4 and Liver |


